Anebulo Pharmaceuticals (ANEB) Income from Continuing Operations (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Income from Continuing Operations of -$2.55 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$2.68 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Income from Continuing Operations (2020 - 2025) Analysis & Trends
Over the twelve months ended Dec 31, 2025, Anebulo Pharmaceuticals' Income from Continuing Operations came in at -$9 million; for FY2025 (ended Jun 30, 2025), it came in at -$9.37 million.
- By fiscal year, Income from Continuing Operations came in at -$8.26 million in FY2024, -$11.69 million in FY2023, -$6.82 million in FY2022 and -$3.61 million in FY2021.
- Five-year quarterly Income from Continuing Operations spans a low of -$3.8 million in fiscal Q2 2023 and a high of -$555,832 in fiscal Q3 2021.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at -$2.17 million (Q1 2026), -$2.24 million (Q4 2025) and -$2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | -2.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Sep 30, 2024 | -2.49 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.49 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -2.78 Mn |
| Dec 31, 2022 | -3.80 Mn |
| Sep 30, 2022 | -2.61 Mn |
| Jun 30, 2022 | -2.33 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -2.47 Mn |
| Mar 31, 2021 | -555,832.00 |
API Access
Anebulo Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();